Blume Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.7K Buy
1,077
+327
+44% +$29.8K 0.01% 164
2026
Q1
$77K Buy
+750
New +$84.7K 0.01% 168
2025
Q2
Sell
-15
Closed -$1.99K 437
2025
Q1
$1.99K Buy
+15
New +$1.91K ﹤0.01% 337
2022
Q3
Sell
-261
Closed -$28K 308
2022
Q2
$28K Buy
+261
New +$29.6K 0.01% 191
2018
Q2
Sell
-119
Closed -$7K 190
2018
Q1
$7K Buy
+119
New +$7.17K ﹤0.01% 179
2017
Q2
Sell
-334
Closed -$15K 198
2017
Q1
$15K Sell
334
-66
-17% -$2.85K 0.01% 144
2016
Q4
$15K Buy
+400
New +$15.9K 0.01% 147
2015
Q1
Sell
-1,000
Closed -$45K 286
2014
Q4
$45K Buy
+1,000
New +$43.6K 0.03% 143

Other funds holding ABT

Blume Capital Management's ABT Position: Q2 2026 in Review

Blume Capital Management increased its Abbott (ABT) stake by 44% in Q2 2026, buying an estimated $29.8K and bringing the position to 1,077 shares worth $97.7K. The position accounts for 0.01% of the portfolio, ranked #164.

Blume Capital Management first reported a position in ABT in Q4 2014 and has held it in 8 quarters since. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Blume Capital Management held 1,077 shares of Abbott worth $97.7K as of Q2 2026.
  • Blume Capital Management bought 327 Abbott shares in Q2 2026, an estimated $29.8K.
  • Abbott made up 0.01% of Blume Capital Management's portfolio in Q2 2026, its #164 holding.
  • Blume Capital Management first reported a position in Abbott in Q4 2014 and has held it in 8 quarters since.
  • 2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.